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rights and permissions. Published by BMJ. INTRODUCTION: Evidence regarding effective communication
between clinicians and patients with inflammatory bowel disease (IBD) is limited. Studies that investigate
clinical communication in IBD are much fewer in number than studies that investigate the perceptions of
patients and clinicians about communication in clinical encounters. The current review aims to identify,
organise and summarise systematically what is currently known about (1) the characteristics of
interactions between clinicians who manage IBD and patients with IBD, and (2) how clinical discussion
affects health outcomes in IBD. METHODS AND ANALYSIS: Scopus, PubMed, Embase, Communication
Abstracts, Health & Society, Linguistics and Language Behavior Abstracts and PsycINFO will be
systematically searched for studies that investigate the characteristics of IBD clinical interactions during
recorded consultations, from earliest available dates within each database to May 2020. A specifically
developed quality assessment tool, grounded in linguistic theory, will be used to critically assess the
evidence. In addition, a data extraction template will be developed and utilised to provide a description of
the characteristics of IBD clinical communication as well as an estimation of its effect on health
outcomes in a narrative synthesis. ETHICS AND DISSEMINATION: Ethical review and approval is not
required for this systematic review as no primary data will be collected. The results will be published in
peer-reviewed journals and presented at academic conferences. PROSPERO REGISTRATION NUMBER:
International Prospective Register of Systematic Reviews (PROSPERO) on 28 April 2020 (registration
number: CRD42020169657).
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ABSTRACT
Introduction Evidence regarding effective communication
between clinicians and patients with inflammatory bowel
disease (IBD) is limited. Studies that investigate clinical
communication in IBD are much fewer in number than
studies that investigate the perceptions of patients and
clinicians about communication in clinical encounters. The
current review aims to identify, organise and summarise
systematically what is currently known about (1) the
characteristics of interactions between clinicians who
manage IBD and patients with IBD, and (2) how clinical
discussion affects health outcomes in IBD.
Methods and analysis Scopus, PubMed, Embase,
Communication Abstracts, Health & Society, Linguistics
and Language Behavior Abstracts and PsycINFO will be
systematically searched for studies that investigate the
characteristics of IBD clinical interactions during recorded
consultations, from earliest available dates within each
database to May 2020. A specifically developed quality
assessment tool, grounded in linguistic theory, will be
used to critically assess the evidence. In addition, a data
extraction template will be developed and utilised to
provide a description of the characteristics of IBD clinical
communication as well as an estimation of its effect on
health outcomes in a narrative synthesis.
Ethics and dissemination Ethical review and approval is
not required for this systematic review as no primary data
will be collected. The results will be published in peer-
reviewed journals and presented at academic conferences.
PROSPERO registration number International
Prospective Register of Systematic Reviews (PROSPERO)
on 28 April 2020 (registration number: CRD42020169657).

INTRODUCTION
Inflammatory bowel disease (IBD) is a
chronic inflammatory condition of the
gastrointestinal tract mainly presenting in two
forms: Crohn’s disease (CD) and ulcerative
colitis (UC). IBD is characterised by intermittent periods of active disease with symptoms including diarrhoea, rectal bleeding,
urgency, incontinence, chronic abdominal
pain, loss of appetite and weight loss, fatigue,
joint pain and skin problems that undermine
patients’ quality of life and emotional well-
being which can affect their personal, social

Strengths and limitations of this study
►► This systematic review will be the very first to

identify, assess and summarise evidence resulting
from investigations of recorded clinical interactions
during IBD consultations.
►► The review will consult a diverse range of databases—including databases with special focus on
medicine, health, psychology, communication and
linguistics— to identify eligible studies.
►► The review will use a specifically developed quality
assessment tool, grounded in linguistic theory, to
critically assess the evidence.
►► It is expected that the findings will not be integrated
to produce cumulative evidence due to the anticipated diverse range of included studies in terms of
context and theoretical underpinnings.
►► Due to funding limitations, this systematic review
will be restricted to publications in English language
only and, thus, may not represent all the available
evidence.

and professional life. The incidence of IBD
is highest among those aged between 15 and
29 years,1 exacerbating the economic burden
of the disease due to effects on the ability
to work of the large young population of
patients with IBD.
Due to the chronicity of IBD, patients
require ongoing monitoring and long-term
maintenance therapy to stay in remission and
prevent recurrence of disease activity. Treatment of IBD has become more effective over
time due to advances in medical and clinical
research and the introduction of more effective drugs. At the same time, it has become
more complicated because of the complex
risk–benefit profile of the more effective
treatments. As a result, discourses around
the role of the patient as a key stakeholder
in decision-making have found more recognition and prominence in IBD research.2 3
Since the main space in which clinicians and
patients negotiate roles and make decisions is
their clinical interaction during consultations,

Karimi N, et al. BMJ Open 2020;10:e039503. doi:10.1136/bmjopen-2020-039503

1

BMJ Open: first published as 10.1136/bmjopen-2020-039503 on 4 November 2020. Downloaded from http://bmjopen.bmj.com/ on November 17, 2020 by guest. Protected by copyright.

Open access

understanding the exchange of meaning between clinicians and patients in this space and its existing variations
is crucial for understanding the bigger picture of how—
and how well—IBD is managed. Such an understanding
can help identify ways in which IBD care can improve.
Effects of clinical communication on health outcomes
include patient satisfaction, adherence, patient quality
of life, disease management and self-
management, as
discussed by a number of studies in the IBD-specific literature and by many more studies concerned with other
conditions. Ghosh and colleagues argued that in IBD,
‘good communication between physician and patient
is a cornerstone of effective disease management’4 (p
S245). The authors suggested that motivational communication may be valuable in IBD care, ‘where the use of
treatments with potentially undesirable side effects must
be balanced against the risk of life-long high morbidity
from the disease’4 (p S247). Motivational communication
is a collaborative approach used to elicit the person’s own
intrinsic motivation and resources for change.5 A survey
study by Mocciaro and colleagues showed that motivational communication in IBD consultations improved
patient satisfaction, and potentially medication adherence and smoking cessation and helped physicians in
dealing with patients ‘moving from ‘cure’ to ‘care’’.6
Highlighting the link between clinical communication and patient quality of life and disease management,
Mitchell and colleagues argued that discussing the
impact of IBD on a patient’s daily life during a consultation can produce a better ‘picture of how patients are
affected by their disease and how well their current treatment strategy is working for them’7 (p2), and provides
a context for considering new treatment options based
on patients’ expectations of treatment, ability to adapt
and treatment objectives. Furthermore, Kennedy and
colleagues pointed out the impact of effective communication on ‘encouraging and supporting decisions and
self-care actions which may enable patients to optimally
manage their condition outside of health service settings’8
(p567–8).
While there has been advocacy for research on communication in IBD, projects whose ‘site of engagement/
intervention’ is the ‘clinician–patient interface’9—that is,
projects that investigate interactions between patients and
clinicians, rather than patients’ perceptions of clinical
communication—are less known. No systematic literature
review has been conducted to identify and review such
studies. In 2004, Husain and Triadafilopoulos pointed to
‘a paucity of data concerning effective communication
methods enabling physicians to develop stronger rapport
with patients suffering from IBD’10 (p444). Sixteen years
later, we still do not know much about the status of IBD
communication from research that uses real-
life clinician–patient conversation data. The current review aims
to ascertain the existing knowledge in this area to inform
the field, identify the gaps and areas that require further
investigations, and position this literature within current
IBD care practice and research. The main objective is to
2

identify, organise and summarise systematically what is
currently known about (1) the characteristics of conversations between clinicians who manage IBD and patients
with IBD, and (2) how clinical discussion affects health
outcomes in IBD.
METHODS
The development of this study protocol was in accordance
to the Preferred Reporting Items for Systematic Review
and Meta-Analysis Protocols (PRISMA-P).11 12 A copy of
the completed PRISMA-P 2015 checklist is presented in
online supplemental appendix 1. This study protocol
is registered with the International Registration of
Systematic reviews (PROSPERO, registration number:
CRD42020169657).
Eligibility criteria
The review will include studies that investigate the characteristics of the interactions between clinicians who manage
patients with IBD and/or their parent/guardian during
a recorded consultation. These characteristics generally
include, but are not limited to, the content of the consultation, patients’ and clinicians’ experience as represented
in their language, the interpersonal meanings exchanged
in the consultation, the different rhetorical steps that
make up the consultation and the flow of information
in the consultation. Studies based only on self-report of
interaction for example, focus group studies, interviews,
surveys or participatory observation with no audio/video
recording will be excluded.
Published peer-reviewed studies in English that used
quantitative or qualitative methods (including, but not
limited to, discourse analysis, conversation analysis and
life interaccontent analysis) to analyse recorded real-
tions between clinicians and patients with IBD (UC or
CD) during a consultation will be included in the review.
Eligible studies will need to sample patients with IBD
and clinicians who manage patients with IBD in primary
and secondary healthcare (eg, general practitioners,
IBD specialists, IBD nurses), complementary medicine
(eg, acupuncturists, traditional Chinese medicine practitioner) or allied health (eg, dietitian). Studies with a
focus on healthcare providers whose primary treatment
includes the interaction itself (eg, psychotherapists) will
be excluded. Studies in which these participant groups
are present but IBD is not the focus of the study will also
be excluded. Studies will be selected regardless of the
type of intervention or exposure as the review will not
be focused on a certain type of intervention or exposure.
Only journal articles and book chapters published in
English are eligible. Peer-reviewed published abstracts,
letters to the editor, editorials and theses will be excluded.
However, ineligible sources will be examined to locate
corresponding journal articles. Articles published up to
May 2020 will be included.
Information sources and search strategy
The review will search for records indexed in:
1. Scopus
Karimi N, et al. BMJ Open 2020;10:e039503. doi:10.1136/bmjopen-2020-039503
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2.
3.
4.
5.
6.
7.

PubMed
Embase
Communication Abstracts
Health & Society
Linguistics and Language Behavior Abstracts
PsycINFO
In addition, snowball sampling will be employed.
Reference lists of eligible articles identified in the online
database search as well as the excluded but relevant
publications will be consulted. Subject matter experts
(those known to the researchers as well as those identified in the database search and snowball sampling) will
be contacted via email and consulted to identify any additional literature.
A relatively broad search strategy will be employed due
to anticipating limited numbers of studies that explore
real-life clinician–patient interactions in IBD and in order
to maximise the reach. Table 1 lists the keywords that will
be used to search these databases. Keywords referring to
the condition or healthcare domain being studied (eg,
IBD) will be used; in conjunction with terms describing
the data type (eg, consultation and audio-record*). The
search strategy will represent the intersection of these two
sets of terms.
Data management and selection process
Study records obtained from the databases will be
exported into Endnote where duplicates will be removed,
and screening of titles and abstracts and then full-text
records will be performed independently by three
reviewers (NK, RK and AL). The reviewers will be overinclusive with their selections and will include all the studies
that appear to meet the inclusion criteria as well as those
whose eligibility for inclusion is uncertain. Reviewers will
not be blinded to the study authors, institutions or journals of the records they screen.
Once the reviewers complete the screening of titles and
abstracts, they will meet to compare their lists of selected
studies and resolve any discrepancies prior to the full-text
review. Any unresolved disagreement will be discussed
with the whole review team and a collective decision will
be made. Reasons for exclusion will also be recorded at
this stage. Once agreement is reached, the full text of the
selected studies will be uploaded in Endnote and studied
independently by the reviewers for final inclusions. The
same discrepancy resolving process will be repeated
at this final stage of selection. Reviewers will meet on
finishing the independent selection process to resolve
any disagreements and will discuss matters with the whole
review team if they cannot reach an agreement.
Data collection and extraction processes
Selected articles will be carefully studied by the whole
team. A data extraction template will be developed based
on the questions asked in the review and the information available in the selected studies, and in consultation
with the existing health communication and linguistics
literature including previous systematic literature reviews
Karimi N, et al. BMJ Open 2020;10:e039503. doi:10.1136/bmjopen-2020-039503

of this kind9 13–16 and Halliday’s theoretical model of
the architecture of language, known as systemic functional linguistics.17 The data extraction template will be
accompanied by detailed instructions in Microsoft Excel
(2007). It will be piloted by two reviewers on a sample of
included papers to ensure the efficiency of the template
and the accuracy and consistency of extractors before the
final data extraction which will be performed by NK and
checked by the review team.
The review will explore potential trends in this strand
of research by comparing the timing of studies (year
of research), the countries in which the studies were
conducted and the type of consultation under scrutiny
(eg, IBD nurse consultations, IBD specialist consultations, etc). Information will be extracted on research
setting, participant characteristics including their role
(eg, patient, parent, nurse, gastroenterologist, etc), sociodemographics and the status of patient participants (eg,
pregnant, preconception, postsurgery, in transition to
adult care, etc), as well as disease characteristics including
type of IBD (UC, CD or IBD unclassified), disease activity,
disease phenotype and extraintestinal manifestations.
Stated aims, aims relevant to the review (eg, investigation of whether/how the clinicians talk about treatment options including their benefits and side effects,
patient’s quality of life or goals of care; description of
clinician–patient relationship as construed in talk; etc),
study design, health outcomes and measures and stated
findings and conclusions will be described for each study.
Information on the consultation data including the size of
the dataset (corpus size), the actual number of consultation/episodes analysed in the study, the average length of
consultations, whether consultations were audio recorded
or video recorded and whether the consultations were
one-off or in series will be charted. Furthermore, the
method of linguistic data analysis and the investigated
linguistic features will be described. A linguistic feature
is broadly defined as any semantic, grammatical or lexical
concept such as topic, question (type and quantity),
length of consultation and so on.
Box 1 outlines the data items that will be included in
the review. Additional items will potentially be added to
this list based on the information available in the selected
papers.
Outcomes and prioritisation
A description of the characteristics of conversations
between clinicians who manage IBD and patients with
IBD (and/or their parent/guardian) during a consultation is the main outcome of this review. These characteristics generally identify the content of the consultation,
patients’ and clinicians’ experience as represented in the
consultation, the interpersonal relationships between
clinician and patient, the different steps involved and the
flow of information in the consultation. Another main
outcome is an estimation of the effect of IBD clinical
discussion on health outcomes (biomedical and psychosocial). Secondary outcomes include a description of the
3
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Abstract

Linguistics and Language
Behavior Abstracts

IBD, inflammatory bowel disease.

All text

Abstract

Health & Society

Text Word (TW)

PsychINFO and EMBASE

Communication Abstracts

Title/abstract/
keyword

Scopus

consultation AND audio record* OR audio-record* OR video record* OR video-record

consultation AND audio record* OR audio-record* OR video record* OR video-record

2. inflammatory bowel disease OR IBD OR ulcerative colitis OR Crohn's disease

consultation AND audio record* OR audio-record* OR video record* OR video-record

2. inflammatory bowel disease OR IBD OR ulcerative colitis OR Crohn's disease

inflammatory bowel disease OR IBD OR ulcerative colitis OR Crohn's disease

inflammatory bowel disease OR IBD OR ulcerative colitis OR Crohn's disease

inflammatory bowel disease OR IBD OR ulcerative colitis OR Crohn's disease

–

–

–

Limit searches to: full text AND human AND English language

communication OR interaction OR doctor–patient OR clinician–patient OR clinical encounter

1. inflammatory bowel disease OR IBD OR ulcerative colitis OR Crohn's disease

Limit searches to: Article and chapter

communication OR interaction OR doctor–patient OR clinician–patient OR clinical encounter

1. inflammatory bowel disease OR IBD OR ulcerative colitis OR Crohn's disease

Limit searches to: full text AND humans

communication OR interaction OR doctor–patient OR clinician–patient OR clinical encounter

Text Word (TW)

PubMed

Search 2

2. inflammatory bowel disease OR IBD OR ulcerative colitis OR Crohn's disease

Search1

Search field

Database

communication
interaction
clinician–patient
doctor–patient
clinical encounter
consultation
audio-record*
audio record*
video-record*
video record*

Data type terms (search 2) AND

1. inflammatory bowel disease OR IBD OR ulcerative colitis OR Crohn's disease

IBD
inflammatory bowel disease
ulcerative colitis
Crohn’s disease

Condition terms (search 1) AND

Complete search strategy for all electronic bibliographic databases

Terms that the below searches are intended
to capture

Table 1
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Box 1

Data items included in the data extraction template

►► Participant characteristics

Participants and numbers
Participant sociodemographics
Additional health status information
►► Disease characteristics
Type of IBD
Disease activity
Disease phenotype
Extraintestinal manifestation
►► Study characteristics
Year of research
Country of research
Research setting and type of consultation
Stated aims
Aims relevant to the review
Study design
Outcomes and measures
Stated findings
Stated conclusions
►► Consultation data and analysis characteristics
Corpus size and number of consultations/episodes analysed in the
study
Average length of consultations
One-off consultation or series
Data type (audio or video)
Method of linguistic data analysis (sociolinguistics, conversation
analysis, content analysis, etc)
Linguistic component/s analysed

characteristics of the existing consultation data available
for scrutiny in the literature, and trends in IBD clinical
communication research including mainstream analytic
approaches.
Risk of bias in individual studies
Conventional guidelines for assessing the quality of
studies for inclusion in a systematic literature review18
have limited application to discourse analytic research
because this type of research is different from the mainstream qualitative and quantitative health research in
terms of its objective and methodology.15 Rather than
using a single set of criteria and ranking studies based
on those criteria, following Parry and Land, two broad
dimensions will be used to assess each study’s value and
contribution: (1) the type and amount of data, and (2)
the credibility and reliability of the analysis.15 Credibility is defined as ‘the confidence that can be placed
in the truth of the research findings’19 (p121). To assess
the credibility of the studies, Matthiessen’s account
of the methodological approaches to the analysis of a
situation type (eg, IBD consultation)20 will be used as a
guide. Matthiessen’s methodological account20 is based
on Halliday’s systemic functional linguistics.21 Generally, language consists of four layers or strata (context,
semantics, grammar and lexis and phonology) and four
main functions (experiential, logical, interpersonal and
textual). Function of language equals ‘use’: what is it that
Karimi N, et al. BMJ Open 2020;10:e039503. doi:10.1136/bmjopen-2020-039503

the language is being used for? The four main functions
(or metafunctions) of language occur simultaneously in
any utterance or text.17 The experiential function allows
language users to use language to construe their experience; the interpersonal function allows language users
to enact their roles and relationships with each other
(eg, status, intimacy, contact, sharedness between interactants); the logical function concerns how language
users create relations between different parts of their
talk, and the textual function is what turns a collection
of individual words into a coherent text.17 22 A comprehensive description of a situation type is time consuming
and labour intensive. Matthiessen suggests principled
selection of data and data analysis tools to reduce the
description bias and increase credibility.20 To assess the
reliability of the studies, information regarding the presence or absence of a second coder and the use of a unit
of analysis will be considered.
Included studies will also be evaluated in terms of the
amount of evidence used to support their conclusions
and whether the conclusions were biassed or evidence
based.23 Further quality assessment dimensions may be
added depending on the included studies. Missing information will not be sought from the authors, neither will
unclear aspects of the studies be clarified with them.
Rather, such limitations will be discussed under risk of
bias.
Synthesis
The extracted data will be presented in overview tables
for the purpose of summarisation and comparison and
described in a narrative synthesis. The inclusion criteria
in this review allow for including studies from a range of
contexts such as IBD specialist consultations, nurse consultations, allied health consultations, and general practice
consultations. It is, therefore, expected that the context of
the included studies will vary. It is also expected that these
studies will be within different research traditions, having
different underpinning philosophical assumptions, given
the diverse approaches to the analysis of talk in health
research, in general. Considering the diversity of contexts
and theoretical underpinnings, a narrative synthesis was
chosen as the method of synthesising data.
The narrative synthesis will be based on the results of
the data extraction and quality appraisal. Furthermore,
following the recommendations of Cochrane Consumers
and Communication Review Group,24 the narrative
synthesis will also include investigation of the similarities
and the differences between the studies based on the
study design and information gathered from the data
extraction and quality appraisal. Since this is not a meta-
synthesis, findings of the included studies will not be integrated, and the data will not be reinterpreted.
Patient and public involvement
There has been no contribution from patients or the
public to the design of this systematic review protocol.
5
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ETHICS AND DISSEMINATION
No human subject participants will be involved. Therefore, ethical approval will not be required. Findings of
this systematic review will be presented at national and
international conferences and published in peer-reviewed
journals (open access if possible). In the event of protocol
amendments, the date of each amendment will be accompanied by a description of the change and the rationale.
DISCUSSION
Clinician–patient communication is shown to affect
biological and functional health outcomes25–29 and
can have economic consequences.30–32 In IBD, clinical
communication is argued to affect patient satisfaction,
treatment adherence, patient quality of life, disease
management and self-management, as described in the
Introduction section. This systematic review will be the
first to review studies that examine clinical communication in IBD using recorded clinician–patient consultation data. It aims to investigate the characteristics of
IBD clinical discussions and the effects of these discussions on health outcomes (biomedical and psychosocial).
The current protocol outlines the steps and procedures
involved in achieving this objective.
Collecting and reviewing evidence from studies that
investigate recorded clinical communication in IBD for
the first time, consulting a diverse range of databases
to identify eligible studies, developing a broad search
strategy to maximise inclusion and using a comprehensive theory of language for appraising the quality of the
included studies are arguably among the strengths of this
review. Nevertheless, there are limitations as well. Reviews
of this kind inevitably include a diverse range of studies in
terms of context and theoretical underpinnings and this
review will not be an exception. The consequence of this
diversity is that findings cannot be integrated to produce
cumulative evidence. For this reason, a narrative synthesis
approach will be taken where data will be summarised
and compared but not statistically integrated. In addition, because of funding limitations, this review will
be restricted to publications in English language only
and, thus, may not represent all the available evidence.
Nevertheless, the results of the review can provide clinicians with valuable information to improve the way they
communicate with their patients during a consultation. It
will also identify the gaps in the literature and the areas
that require further investigation for future research.
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